Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
25.54
-1.46 (-5.41%)
Nov 6, 2026, 4:00 PM EST - Market closed

Arcutis Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
33.3742.9171.3488.453.6496.45
Short-Term Investments
226.09178.08156.62183.46355.95290.61
Cash & Short-Term Investments
259.46220.98227.96271.86409.59387.06
Cash Growth
35.80%-3.06%-16.15%-33.63%5.82%36.08%
Accounts Receivable
171.28146.2373.0725.818.46-
Receivables
171.28146.2373.0725.818.46-
Inventory
45.6722.6314.5313.137.51-
Prepaid Expenses
19.1211.5912.2910.17.3914.17
Restricted Cash
0.310.310.620.931.231.54
Other Current Assets
7.859.497.378.613.23-
Total Current Assets
503.69411.23335.82330.43437.41402.77
Property, Plant & Equipment
4.945.512.993.94.65.3
Other Intangible Assets
13.1314.819.486.447.19-
Other Long-Term Assets
2.671.420.60.60.080.08
Total Assets
524.43432.97348.89341.37449.27408.15

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
8.3412.5314.2211.998.837.35
Accrued Expenses
147.87116.0266.7933.9428.3225.54
Current Portion of Long-Term Debt
6.951----
Current Portion of Leases
-0.29-0.740.660.43
Total Current Liabilities
172.36129.8481.0146.6737.8133.33
Long-Term Debt
102.45107.96107.2201.8197.7772.35
Long-Term Leases
5.225.272.563.384.124.77
Other Long-Term Liabilities
0.430.430.570.85-0.03
Total Liabilities
280.46243.49191.35252.7239.69110.48

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,3711,3281,2791,071930.43706.23
Retained Earnings
-1,126-1,138-1,122-981.9-719.76-408.31
Comprehensive Income & Other
-1.17-0.04-0.010-1.09-0.26
Total Common Equity
243.97189.48157.5488.67209.58297.68
Shareholders' Equity
243.97189.48157.5488.67209.58297.68
Total Liabilities & Equity
524.43432.97348.89341.37449.27408.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
123.82114.52109.77205.92202.5477.56
Net Cash (Debt)
135.64106.46118.1965.95207.05309.5
Net Cash Growth
75.49%-9.92%79.22%-68.15%-33.10%10.74%
Net Cash Per Share
1.010.840.980.953.766.26
Filing Date Shares Outstanding
126.46124.03118.6496.8161.0850.38
Total Common Shares Outstanding
126.02123.33117.8596.7961.0450.26
Working Capital
331.33281.39254.81283.76399.6369.45
Book Value Per Share
1.941.541.340.923.435.92
Tangible Book Value
230.84174.67148.0682.23202.39297.68
Tangible Book Value Per Share
1.831.421.260.853.325.92
Machinery
-2.621.931.791.361.12
Leasehold Improvements
-1.571.571.571.571.57
SEC Filings: 10-K · 10-Q